Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Delays Release of 2004 10-K Due to December Departure of CFO Spicer

NEW YORK, March 18 (GenomeWeb News) - Orchid Biosciences has delayed the release of its 10-K 2004 earnings report due to the recent departure of CFO Mike Spicer, and because the SEC now considers Orchid to be an accelerated filer, the company said in a document filed with the SEC yesterday.

 

The company issued a press release reporting its fourth-quarter and year-end 2004 earnings earlier this month. The company said it will file the form by March 31.

In today's SEC filing, Orchid said the delay occured because 2005 is "the first year that the Registrant is an accelerated filer for purposes of filing its periodic reports and the Resitrant's  Chief Financial Officer, whio is charged with the primary responsibility for preparing the Form 10-K and its supporting schedules, resigned effective as of December 31, 2004."

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.